Relationship between the apolipoprotein E and angiotensin-converting enzyme genotypes and LDL particle size in Japanese subjects

Clinica Chimica Acta

Volumn 285, Issue 1-2, 1999, Pages 91-103

  Okumura, Kenji ^a   Kaneko, Shinji ^a   Morishima, Itsuro ^a   Mokuno, Shinji ^a   Toki, Yukio ^a   Hayakawa, Tetsuo ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiotensin converting enzyme; Apolipoprotein E; Genotype; Japanese; LDL particle size

Indexed keywords

APOLIPOPROTEIN E; DIPEPTIDYL CARBOXYPEPTIDASE; LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; DNA DETERMINATION; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN EXPERIMENT; JAPAN; MALE; NORMAL HUMAN; PARTICLE SIZE; PRIORITY JOURNAL;

ADULT; AGED; APOLIPOPROTEINS E; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; JAPAN; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; PARTICLE SIZE; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC;

EID: 0345211529     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(99)00108-4     Document Type: Article

References (52)

1. Cambien F, Poirier O, Lecerf L et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992;359:641-4.
2. Markus HS, Barley J, Lunt R et al. Angiotensin-converting enzyme gene deletion polymorphism: a new risk factor for lacunar stroke but not carotid atheroma. Stroke 1995;126:1329-33.
3. Missouris CG, Barley J, Jeffery S, Carter ND, Singer DRJ, MacGregor GA. Genetic risk for renal artery stenosis: association with deletion polymorphism in angiotensin I-converting enzyme gene. Kidney Int 1996;49:534-7.
4. Lindpaintner K, Pfeffer MA, Kreutz R et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995;332:706-11.
5. Lindpaintner K, Hennekens CH. Angiotensin-converting-enzyme genotype and ischemic heart disease. N Engl J Med 1995;333:459-60.
6. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988;8:1-21.
7. Ou T, Yamakawa-Kobayashi K, Arinami T et al. Methyenetetrahydrofolate reductase and apolipoprotein E polymorphisma are independent risk factors for coronary heart disease in Japanese: a case-control study. Atherosclerosis 1998;137:23-8.
8. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990;31:545-8.
9. Castelli WP, Carrison RJ, Wilson PWF, Abbott RD, Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham Study. JAMA 1986;256:2835-8.
10. Shen MMS, Krauss RM, Lindgren FT, Forte TM. Heterogenecity of serum low density lipoprotein in normal human subjects. J Lipid Res 1981;22:236-44.
11. Gambert P, Bouzerand-Gambert C, Athias A, Farnier M, Lallemant C. Human low density lipoprotein subfractions separated by gradient gel electrophoresis: composition, distribution, and alterations induced by cholesteryl ester transfer protein. J Lipid Res 1990;31:1199-210.
12. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 1988;260:1917-21.
13. Crouse JR, Parks JS, Schey HM. Studies of low density lipoprotein molecular weight in human beings with coronary artery disease. J Lipid Res 1985;26:566-74.
14. Haffner SM, Mykkänen L, Stern MP, Paidi M, Howard BV. Greater effect of diabetes on LDL size in women than in men. Diabetes Care 1994;17:1164-71.
15. Singh ATK, Rainwater DL, Haffner SM et al. Effect of diabetes on lipoprotein size. Arterioscler Thromb Vasc Biol 1995;15:1805-11.
16. Iwai M, Yoshino G, Matsushita M et al. Abnormal lipoprotein composition in normolipidemic diabetic patients. Diabetes Care 1990;13:792-6.
17. Williams PT, Krauss RM. Associations of age, adiposity, menopause, and alcohol intake with low-density lipoprotein subclasses. Arterioscler Thromb Vasc Biol 1997;17:1082-90.
18. Reaven GM, Chen YD, Jeppesen J, Maheux P, Krauss RM. Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles. J Clin Invest 1993;92:141-6.
19. Austin MA, King MC, Vranian KM, Krauss RM. Atherogenic lipoprotein phenotype: a proposed genetic marker for coronary heart disease risk. Circulation 1990;82:495-506.
20. McNamara JR, Campos H, Ordovas JM, Perterson J, Wilson PWF, Schaefer EJ. Effect of gender, age, and lipid status on low-density lipoprotein subfraction distribution: results from the Framingham offspring study. Arteriosclerosis 1987;7:483-90.
21. McNamara JR, Jenner JL, Li Z, Wilson PWF, Schaefer EJ. Change in LDL particle size is associated with change in plasma triglyceride concentration. Arterioscler Thromb 1992;12:1284-90.
22. Katzel LI, Coon PJ, Rogus E, Krauss RM, Goldberg AP. Persistence of low HDL-C levels after weight reduction in older men with small LDL particles. Arterioscler Thromb Vasc Biol 1995;15:299-305.
23. Nishina PM, Johnson JP, Naggert JK, Krauss RM. Linkage of atherogenic lipoprotein phenotype to the low density lipoprotein receptor on the short arm of chromosome 19. Proc Natl Acad Sci USA 1992;89:708-12.
24. Pablos-Méndez A, Mayeux R, Ngai C, Shea S, Berglund L. Association of Apo E polymorphism with plasma lipid levels in a multiethnic elderly population. Arterioscler Thromb Vasc Biol 1997;17:3534-41.
25. Zaman MM, Ikemoto S, Yoshiike N, Date C, Yokoyama T, Tanaka H. Association of apolipoprotein genetic polymorphisms with plasma cholesterol in a Japanese rural population: the Shibata study. Arterioscler Thromb Vasc Biol 1997;17:3495-504.
26. Haffner SM, Stern MP, Miettinen H, Robbins D, Howard BV Apolipoprotein E polymorphism and LDL size in a biethnic population. Arterioscler Thromb Vasc Biol 1996;16:1184-8.
27. Bøyum A. Isolation of mononuclear cells and granulocytes from human blood. Scan J Clin Lab Invest Suppl 1968;97:77-89.
28. Lechin M, Quiñones MA, Omran A et al. Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy. Circulation 1995;92:1808-12.
29. Okumura K, Matsui H, Kawakami K et al. Low density lipoprotein particle size is associated with glycosylated hemoglobin levels regardless of plasma lipid levels. Internal Med 1998;37:273-9.
30. Krauss RM, Burke DJ. Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res 1982;23:97-104.
31. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
32. Nakata Y, Katsuya T, Rakugi H et al. Polymorphism of the apolipoprotein E and angiotensin-converting enzyme genes in Japanese subjects with silent myocardial ischemia. Hypertension 1996;27:1205-9.
33. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86:1343-6.
34. Cambien F, Costerousse O, Tiret L et al. Plasma level and gene polymorphism of the angiotensin-converting enzyme in relation to myocardial infarction. Circulation 1994;90:669-76.
35. Coxterousse O, Allegrini J, Lopez M, Alhenc-Gelas F. Angiotensin I-converting enzyme in the human circulating mononuclear cells: genetic polymorphism of expression in T lymphocytes. Biochem J 1993;290:33-40.
36. Katsuya T, Horiuchi M, Chen YDI et al. Relations between depletion polymorphism of the angiotensin-converting enzyme gene and insulin resistance, glucose intolerance, hyperin-sulinemia, and dyslipidemia. Arterioscler Thromb Vasc Biol 1995;15:779-82.
37. Staessen JA, Wang JG, Ginocchio G et al. The deletion/insertion polymorphism of the angiotensin converting enzyme gene cardiovascular-renal risk. J Hypertens 1997;15:1579-92.
38. Margaglione M, Celentano E, Grandone E et al. Depletion polymorphism in the angiotensin-converting enzyme gene in patients with a history of ischemic stroke. Arterioscler Thromb Vasc Biol 1996;16:304-9.
39. Walden CC, Hegele RA. Apolipoprotein E in Hyperlipidemia. Ann Intern Med 1994;120:1026-36.
40. Cattin L, Fisicaro M, Tonizzo M et al. Polymorphism of the apolipoprotein E gene and early carotid atherosclerosis defined by ultrasonography in asymptomatic adults. Arterioscler Thromb Vasc Biol 1997;17:91-4.
41. Selby JV, Austin MA, Newman B et al. LDL subclass phenotypes and the insulin resistance syndrome in women. Circulation 1993;88:381-7.
42. Barbagallo CM, Levine GA, Blanche PJ, Ishida BY, Krauss RM. Influence of Apo E content on receptor binding of large, buoyant LDL in subjects with different LDL subclass phenotypes. Arterioscler Thromb Vasc Biol 1998;18:466-72.
43. Camejo G, Hurt-Camejo E, Bondiers G. Effect of proteoglycans on lipoprotein-cell interactions: possible contribution to atherogenesis. Curr Opin Lipidol 1990;1:431-6.
44. Bioletto S, Fontana P, Darioli R, James RW Apolipoprotein E polymorphism and the distribution profile of very low density lipoproteins; an influence of the E4 allele on large (Sf>60) particles. Atherosclerosis 1998;138:207-15.
45. deGraaf J, Haklemmens HLM, Hectors MPC, Demacker PNM, Hendricks JCM, Stalenhoef AFH. Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arterioscler Thromb 1991;11:298-306.
46. Tribble DL, Holl LG, Wood PD, Krauss RM. Variations in oxidative susceptibility among six low density lipoprotein subfractions of different density and particle size. Atherosclerosis 1992;93:189-94.
47. Beard CM, Barnard RJ, Robbins DC, Ordovas JM, Schaefer EJ. Effects of diet and exercise on qualitative and quantitative measures of LDL and its susceptibility to oxidation. Arterioscler Thromb Vasc Biol 1996;16:201-7.
48. Wang XL, McCredie RM, Wilcken DEL. Polymorphisms of the apolipoprotein E gene and severity of coronary artery disease defined by angiography. Arterioscler Thromb Vasc Biol 1995;15:1030-4.
49. Gregg RE, Zech LA, Schaefer EJ, Stark D, Wilson D, Brewer Jr. HB. Abnormal in vivo metabolism of apolipoprotein E4 in humans. J Clin Invest 1986;78:815-21.
50. Demant T, Bedford D, Packard CJ, Shepherd J. Influence of apolipoprotein E polymorphism on apolipoprotein B-100 metabolism in normolipidemic subjects. J Clin Invest 1991;88:1490-501.
51. Kesäniemi YA, Ehnholm C, Miettinen TA. Intestinal cholesterol absorption efficiency in man is related to apolipoprotein E phenotype. J Clin Invest 1987;80:578-81.
52. Gylling H, Kontula K, Miettinen TA. Cholesterol absorption and metabolism and LDL kinetics in healthy men with different apoprotein E phenotypes and apoprotein B XbaI and LDL receptor PvuII genotypes. Arterioscler Thromb Vasc Biol 1995;15:208-13.